Chagas disease/Leishmaniasis program (Daiichi Sankyo/Drugs for Neglected Diseases initiative)

N/A

Report date: 2025/03/14 16:17:28
NME

Base Information

Drug NameChagas disease/Leishmaniasis program (Daiichi Sankyo/Drugs for Neglected Diseases initiative)
Drug Alias NameChagas disease program (Daiichi Sankyo/Drugs for Neglected Diseases initiative)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChagas DiseaseLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsChagas DiseaseLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A